As cases of coronavirus disease 2019 (COVID-19) mount worldwide, attention is needed on
potential long-term neurologic impacts for the majority of patients who experience mild to …

Background A fraction of patients with asymptomatic to mild/moderate acute COVID-19
disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to …

Neuropsychiatric complications associated with coronavirus disease 2019 caused by the
Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies …

Background Cognitive manifestations associated with the severity of a novel coronavirus
(COVID-19) infection are unknown. An early detection of neuropsychological manifestations …

Objective A subset of individuals with coronavirus disease 2019 (COVID-19) appears to
develop persisting cognitive and medical symptoms. Research in the acute stages of illness …

Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization.
However, some develop prolonged symptoms. We sought to characterize the spectrum of …

Objective: To date, very few studies investigating neurocognitive deficits in COVID-19 have
been published. This case series addresses cognition in post-COVID-19 patient by …

Abstract The coronavirus (COVID-19) pandemic is still evolving, causing hundreds of
millions of infections around the world. The long-term sequelae of COVID-19 and neurologic …

Patients with post-coronavirus disease 2019 (COVID-19) conditions typically experience
cognitive problems. Some studies have linked COVID-19 severity with long-term cognitive …

Background and purpose Neurological sequelae from coronavirus disease 2019 (COVID‐
19) may persist after recovery from acute infection. Here, the aim was to describe the natural …